Skip to main content
. 2023 Jul 21;15(7):2000. doi: 10.3390/pharmaceutics15072000

Figure 1.

Figure 1

Graphic abstract of one ‘driver chemical group’ triggering inverse downstream signaling. (A) The abridged general view of NTSR1 antagonist SR48692 and full agonist ML301 inducing activation/deactivation signal transduction via the switch function of F3537.42. (B) The structure and biological activity of SR48692 and ML301.